// App-Quantinova.ai

P337 : Switching from originator infliximab to CT-P13: single-centre experience from the UK

Researchers

Presenter

  • A P Bhandare

Principal Investigators

  • B Crooks

  • G B Nigam

  • J K Limdi

Medical Centers

  • Pennine Acute Hospitals Trust, Gastroenterology, Manchester, UK

  • University of Manchester, Institute of Inflammation and Repair, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • Infliximab Biosimilar

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved